Dimitra Kalemaki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Dimitra Kalemaki has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Stamatis Karakonstantis
University Hospital of Heraklion, Internal Medicine Department, 71110 Heraklion, Greece
14 shared publications Charalampos Lydakis
A The Second Department of Internal Medicine , Venizeleio Pananeio General Hospital of Heraklion , Heraklion , Greece
3 shared publicationsEmmanouil Tzagkarakis
A The Second Department of Internal Medicine , Venizeleio Pananeio General Hospital of Heraklion , Heraklion , Greece
2 shared publicationsAsimina Koulouridi
Department of Internal Medicine B, Venizeleio Pananeio General Hospital, Heraklion, Greece
1 shared publicationDafni Korela
2nd Department of Internal Medicine, General Hospital of Heraklion "Venizeleio-Pananeio", Leoforos Knossou, 71409, Heraklion, Greece
1 shared publication- Despoina Galani
2nd Department of Internal Medicine, General Hospital of Heraklion "Venizeleio-Pananeio", Heraklion, Greece
1 shared publication
Latest Publications
- 29 October 2018
- Published by Taylor & Francis in Infectious Diseases
- Vol. 50 (11-12) , 791-803
A significant percentage of patients with transrectal biopsy-related infections have positive blood cultures but negative urine cultures. A literature review and meta-analysis
Background: Infectious complications after transrectal prostate biopsy are rare. Nevertheless, since these are frequent procedures, the burden of infectious complications is high. Considering the increasing antimicrobial resistance, microbiological confirmation is important to guide antimicrobial therapy. Methods: We reviewed PubMed for original studies providing concurrent urine and blood culture data in symptomatic patients with transrectal biopsy-related infectious complications. We performed a proportions meta-analysis (with MedCalc) and calculated the pooled yield of urine and blood cultures and the pooled discordance rate between urine and blood cultures. Results: Our review identified 41 studies, involving 852 patients with infectious complications after transrectal prostate biopsy and sufficient data to calculate discordance. The pooled yield of urine cultures was 64.6% (95% CI: 56.2–72.3%, I2 83%), the pooled yield of blood cultures was 43% (95% CI: 36.5–49.7%, I2 74%) and the pooled discordance rate was 14% (95% CI: 10.6–17.8%, I2 53%). In subgroup analyses the pooled discordance was; 19.6% (95% CI: 11.8–28.9%, I2 31%) in 113 patients presenting within 2 calendar days after the biopsy and 11.2% (95% CI: 4.5–20%, I2 47%) in 143 patients presenting with fever and symptoms of lower urinary tract symptoms. The statistical and methodological heterogeneity of included studies was high. Conclusion: Obtaining blood cultures is reasonable in all patients presenting with systemic symptoms suggestive of infection after a transrectal prostate biopsy. Blood cultures can provide additional microbiological data in about 1 of 7 patients with post-biopsy infectious complications. Prospective studies are needed to validate these results.
- 29 October 2018
- Published by Taylor & Francis in Infectious Diseases
- Vol. 50 (11-12) , 791-803
A significant percentage of patients with transrectal biopsy-related infections have positive blood cultures but negative urine cultures. A literature review and meta-analysis
Background: Infectious complications after transrectal prostate biopsy are rare. Nevertheless, since these are frequent procedures, the burden of infectious complications is high. Considering the increasing antimicrobial resistance, microbiological confirmation is important to guide antimicrobial therapy. Methods: We reviewed PubMed for original studies providing concurrent urine and blood culture data in symptomatic patients with transrectal biopsy-related infectious complications. We performed a proportions meta-analysis (with MedCalc) and calculated the pooled yield of urine and blood cultures and the pooled discordance rate between urine and blood cultures. Results: Our review identified 41 studies, involving 852 patients with infectious complications after transrectal prostate biopsy and sufficient data to calculate discordance. The pooled yield of urine cultures was 64.6% (95% CI: 56.2–72.3%, I2 83%), the pooled yield of blood cultures was 43% (95% CI: 36.5–49.7%, I2 74%) and the pooled discordance rate was 14% (95% CI: 10.6–17.8%, I2 53%). In subgroup analyses the pooled discordance was; 19.6% (95% CI: 11.8–28.9%, I2 31%) in 113 patients presenting within 2 calendar days after the biopsy and 11.2% (95% CI: 4.5–20%, I2 47%) in 143 patients presenting with fever and symptoms of lower urinary tract symptoms. The statistical and methodological heterogeneity of included studies was high. Conclusion: Obtaining blood cultures is reasonable in all patients presenting with systemic symptoms suggestive of infection after a transrectal prostate biopsy. Blood cultures can provide additional microbiological data in about 1 of 7 patients with post-biopsy infectious complications. Prospective studies are needed to validate these results.
- 1 June 2018
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 36 (6) , 1109-1110
Symptomatic relief as an outcome in studies of nasogastric decompression in small bowel obstruction
- 1 June 2018
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 36 (6) , 1109-1110
Symptomatic relief as an outcome in studies of nasogastric decompression in small bowel obstruction
- 6 March 2018
- Published by Taylor & Francis in Infectious Diseases
- Vol. 50 (8) , 584-592
Blood culture useful only in selected patients with urinary tract infections – a literature review
Purpose: The practice of obtaining blood culture in febrile urinary tract infections is controversial, considering that blood cultures rarely provide additional useful information compared to urine cultures alone. Furthermore, whether a longer treatment duration is necessary in bacteremic patients is also controversial. Here, we aim to review to relevant studies. Materials and methods: We searched PubMed and Scopus for studies providing information regarding the discordance between urine and blood cultures. We also searched for clinical trials regarding the treatment duration in bacteremic patients with urinary tract infections. Results: It seems that a higher likelihood of a negative urine culture (e.g. in patients with antibiotic pre-treatment) combined with a higher likelihood of a positive blood culture (e.g. patients with high fever, or patients with complicated urinary tract infections) increases the chance that a blood culture might provide additional useful information. Furthermore, when polymicrobial infection or contamination of the urine specimen is likely (e.g. in patients with indwelling urinary tract catheters or bedridden patients with frequent hospitalizations and catheterizations), blood cultures may help identify the clinically significant pathogen and guide the choice of the antimicrobial regimen. Finally, because bacteremia has been associated with more severe disease and worse outcomes, some authors suggest a longer treatment duration for bacteremic patients. However, whether the presence of bacteremia should alter the duration of treatment remains unclear. Conclusions: Obtaining blood cultures may be useful in selected patients. Randomized controlled trials are needed to clarify the value of bacteremia in guiding the duration of antimicrobial therapy.
- 6 March 2018
- Published by Taylor & Francis in Infectious Diseases
- Vol. 50 (8) , 584-592
Blood culture useful only in selected patients with urinary tract infections – a literature review
Purpose: The practice of obtaining blood culture in febrile urinary tract infections is controversial, considering that blood cultures rarely provide additional useful information compared to urine cultures alone. Furthermore, whether a longer treatment duration is necessary in bacteremic patients is also controversial. Here, we aim to review to relevant studies. Materials and methods: We searched PubMed and Scopus for studies providing information regarding the discordance between urine and blood cultures. We also searched for clinical trials regarding the treatment duration in bacteremic patients with urinary tract infections. Results: It seems that a higher likelihood of a negative urine culture (e.g. in patients with antibiotic pre-treatment) combined with a higher likelihood of a positive blood culture (e.g. patients with high fever, or patients with complicated urinary tract infections) increases the chance that a blood culture might provide additional useful information. Furthermore, when polymicrobial infection or contamination of the urine specimen is likely (e.g. in patients with indwelling urinary tract catheters or bedridden patients with frequent hospitalizations and catheterizations), blood cultures may help identify the clinically significant pathogen and guide the choice of the antimicrobial regimen. Finally, because bacteremia has been associated with more severe disease and worse outcomes, some authors suggest a longer treatment duration for bacteremic patients. However, whether the presence of bacteremia should alter the duration of treatment remains unclear. Conclusions: Obtaining blood cultures may be useful in selected patients. Randomized controlled trials are needed to clarify the value of bacteremia in guiding the duration of antimicrobial therapy.
- Open Access
- 1 March 2018
- Published by Korean Society of Infectious Diseases and Korean Society for Chemotherapy in Infection & Chemotherapy
- Vol. 50 (1) , 48-49
Is Taking Blood Cultures Indicated in Acute Pyelonephritis Patients Who Have Used Antibiotics before Presentation?
- 1 March 2018
- Published by Korean Society of Infectious Diseases and Korean Society for Chemotherapy in Infection & Chemotherapy
- Vol. 50 (1) , 48-49
Open AccessIs Taking Blood Cultures Indicated in Acute Pyelonephritis Patients Who Have Used Antibiotics before Presentation?
- 28 February 2018
- Published by Taylor & Francis in Infectious Diseases
- Vol. 50 (9) , 648-659
The clinical significance of concomitant bacteriuria in patients with Staphylococcus aureus bacteremia. A review and meta-analysis
Background: Staphylococcus aureus bacteriuria (SABU) concomitant to S. aureus bacteremia (SAB) has been associated with deep-seated infections and worse prognosis. However, the relevant studies were small and inconsistent. Here, we aim to provide a review of the relevant literature, and a meta-analysis of these studies. Methods: We searched PubMed and Scopus for studies comparing patients with SAB and concomitant SABU to patients with SAB without SABU. Results: Nine relevant studies were identified, involving 1429 patients with SAB, of whom 18.5% (n = 265) had concomitant SABU. Pooling the results of those studies, SABU was significantly associated with endocarditis, bone/joint infection and septic embolism. SABU was also associated with persistent SAB, and higher mortality. Conclusions: Although SABU may be a useful marker of complicated SAB, the current literature has several limitations. Larger prospective studies are required to clarify the value of SABU in clinical decision making.
- 28 February 2018
- Published by Taylor & Francis in Infectious Diseases
- Vol. 50 (9) , 648-659
The clinical significance of concomitant bacteriuria in patients with Staphylococcus aureus bacteremia. A review and meta-analysis
Background: Staphylococcus aureus bacteriuria (SABU) concomitant to S. aureus bacteremia (SAB) has been associated with deep-seated infections and worse prognosis. However, the relevant studies were small and inconsistent. Here, we aim to provide a review of the relevant literature, and a meta-analysis of these studies. Methods: We searched PubMed and Scopus for studies comparing patients with SAB and concomitant SABU to patients with SAB without SABU. Results: Nine relevant studies were identified, involving 1429 patients with SAB, of whom 18.5% (n = 265) had concomitant SABU. Pooling the results of those studies, SABU was significantly associated with endocarditis, bone/joint infection and septic embolism. SABU was also associated with persistent SAB, and higher mortality. Conclusions: Although SABU may be a useful marker of complicated SAB, the current literature has several limitations. Larger prospective studies are required to clarify the value of SABU in clinical decision making.
- 16 January 2018
- Published by Springer Nature in Infection
- Vol. 46 (2) , 281-282
Is bacteremia the decisive factor for the duration of antimicrobial therapy in bacteremic urinary tract infections?
- 16 January 2018
- Published by Springer Nature in Infection
- Vol. 46 (2) , 281-282
Is bacteremia the decisive factor for the duration of antimicrobial therapy in bacteremic urinary tract infections?
- Open Access
- 1 January 2018
- Published by Open Access Text Pvt, Ltd. in General Internal Medicine and Clinical Innovations
- Vol. 3 (1)
The common pitfall in studies of biomarkers for diagnosing infections in patients with systemic lupus erythematosus
- 1 January 2018
- Published by Open Access Text Pvt, Ltd. in General Internal Medicine and Clinical Innovations
- Vol. 3 (1)
Open AccessThe common pitfall in studies of biomarkers for diagnosing infections in patients with systemic lupus erythematosus
- Open Access
- 1 January 2018
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 66, 144
Correspondence regarding “Changes in eosinophil count during bacterial infection: revisiting an old marker to assess the efficacy of antimicrobial therapy”
- 1 January 2018
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 66, 144
Open AccessCorrespondence regarding “Changes in eosinophil count during bacterial infection: revisiting an old marker to assess the efficacy of antimicrobial therapy”
- Open Access
- 20 November 2017
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 66 (2) , 417-418
Neutrophil to Lymphocyte Ratio As a Risk Stratification Tool for Older Adults with Pneumonia
See the Reply by Cataudella et al.
- 20 November 2017
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 66 (2) , 417-418
Open AccessNeutrophil to Lymphocyte Ratio As a Risk Stratification Tool for Older Adults with Pneumonia
See the Reply by Cataudella et al.
- 11 November 2017
- Published by Springer Nature in Infection
- Vol. 46 (3) , 293-301
Evaluation and management of Staphylococcus aureus bacteriuria: an updated review
There is little guidance regarding the evaluation and management of patients with Staphylococcus aureus bacteriuria (SABU). Here, we aimed to provide an up-to-date review of the literature.
- 11 November 2017
- Published by Springer Nature in Infection
- Vol. 46 (3) , 293-301
Evaluation and management of Staphylococcus aureus bacteriuria: an updated review
There is little guidance regarding the evaluation and management of patients with Staphylococcus aureus bacteriuria (SABU). Here, we aimed to provide an up-to-date review of the literature.